SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Mattias Mandorfer, Berit A. Payer, Philipp Schwabl, Sebastian Steiner, Arnulf Ferlitsch, Maximilian C. Aichelburg, Albert F. Stättermayer, Peter Ferenci, Barbara Obermayer-Pietsch, Katharina Grabmeier-Pfistershammer, Michael Trauner, Markus Peck-Radosavljevic, Thomas Reiberger, Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3, Liver International, 2015, 35, 2
  2. 2
    Fred Poordad, Christophe Hezode, Roger Trinh, Kris V. Kowdley, Stefan Zeuzem, Kosh Agarwal, Mitchell L. Shiffman, Heiner Wedemeyer, Thomas Berg, Eric M. Yoshida, Xavier Forns, Sandra S. Lovell, Barbara Da Silva-Tillmann, Christine A. Collins, Andrew L. Campbell, Thomas Podsadecki, Barry Bernstein, ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis, New England Journal of Medicine, 2014, 370, 21, 1973

    CrossRef

  3. 3
    Chung-Feng Huang, Chia-Yen Dai, Ming-Lun Yeh, Ching-I Huang, Chi-Ming Tai, Meng-Hsuan Hsieh, Po-Cheng Liang, Yi-Hung Lin, Ming-Yen Hsieh, Hua-Ling Yang, Jee-Fu Huang, Zu-Yau Lin, Shinn-Cherng Chen, Ming-Lung Yu, Wan-Long Chuang, Association of diabetes and PNPLA3 genetic variants with disease severity of patients with chronic hepatitis C virus infection, Journal of Hepatology, 2014,

    CrossRef

  4. 4
    Jason Grebely, Bart Grady, Behzad Hajarizadeh, Kimberly Page, Gregory J. Dore, Disease progression during advanced fibrosis: IL28B genotype or HCV RNA levels?, Hepatology, 2014, 59, 4
  5. 5
    Fasiha Kanwal, Jennifer R. Kramer, Jawad Ilyas, Zhigang Duan, Hashem B. El-Serag, HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV, Hepatology, 2014, 60, 1
  6. 6
    Julien Vergniol, V. de Lédinghen, HCV: Fibrosis Progression, Current Hepatology Reports, 2014, 13, 4, 265

    CrossRef

  7. 7
    Conrado M. Fernández Rodriguez, Maria Luisa Gutierrez Garcia, Impacto del tratamiento antiviral en la historia natural del virus de la hepatitis C, Gastroenterología y Hepatología, 2014, 37, 10, 583

    CrossRef

  8. 8
    Timothy Sheahan, Naoko Imanaka, Svetlana Marukian, Marcus Dorner, Peng Liu, Alexander Ploss, Charles M. Rice, Interferon Lambda Alleles Predict Innate Antiviral Immune Responses and Hepatitis C Virus Permissiveness, Cell Host & Microbe, 2014, 15, 2, 190

    CrossRef

  9. 9
    Matthew T Kitson, Jacob George, Gregory J Dore, Reynold Leung, Peter Button, Geoffrey W McCaughan, Darrell H G Crawford, William Sievert, Martin D Weltman, Wendy S C Cheng, Stuart K Roberts, Interleukin-28B rs12979860 C allele: Protective against advanced fibrosis in chronic hepatitis C genotype 1 infection, Journal of Gastroenterology and Hepatology, 2014, 29, 7
  10. 10
    Mazen Noureddin, Elizabeth C. Wright, Marc G. Ghany, Reply, Hepatology, 2014, 59, 4
  11. 11
    A. F. Stättermayer, T. Scherzer, S. Beinhardt, K. Rutter, H. Hofer, P. Ferenci, Review article: genetic factors that modify the outcome of viral hepatitis, Alimentary Pharmacology & Therapeutics, 2014, 39, 10
  12. 12
    Kentaro Matsuura, Tsunamasa Watanabe, Yasuhito Tanaka, Role of IL28B for chronic hepatitis C treatment toward personalized medicine, Journal of Gastroenterology and Hepatology, 2014, 29, 2